Companies / MRNA vs AMGN
MRNA vs AMGN: Moderna and Amgen
Moderna (MRNA) reported $1.9B in revenue against a -145.2% net margin, while Amgen (AMGN) reported $36.8B at a 21.0% net margin, most recently.
| Metric | MRNA | AMGN |
|---|---|---|
| Revenue | $1.9B | $36.8B |
| Net Income | $-2.8B | $7.7B |
| Gross Margin | 55.3% | 67.2% |
| Operating Margin | -158.1% | 24.7% |
| EPS (Diluted) | $-7.26 | $14.23 |
| Free Cash Flow | $-2.1B | $8.1B |
| Total Debt | $0.6B | $54.6B |
| P/E Ratio | n/m | 23.0× |
| P/B Ratio | 1.3× | 20.4× |
| Stock Price | $241.26 | $463.61 |
Free: last 5 years
| Fiscal year | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| MRNA Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | $18.5B | $19.3B | $6.8B | $3.2B | $1.9B |
| AMGN Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | $26.0B | $26.3B | $28.2B | $33.4B | $36.8B |